{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:03:13Z","timestamp":1795017793477,"version":"4.10.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 62272327 and 12371527"],"award-info":[{"award-number":["No. 62272327 and 12371527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-026-01307-9","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:43:49Z","timestamp":1774788229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of\u00a0a novel triglyceride-glucose and non-HDL-to-HDL cholesterol ratio (TyG-NHHR) index with cardiometabolic multimorbidity: a dual-cohort prospective study in Chinese and European adults"],"prefix":"10.1186","volume":"45","author":[{"given":"Yilin","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"1307_CR1","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204-22."},{"issue":"6","key":"1307_CR2","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2468-2667(17)30074-9","volume":"2","author":"M Kivim\u00e4ki","year":"2017","unstructured":"Kivim\u00e4ki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120\u2008813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277-85.","journal-title":"Lancet Public Health"},{"key":"1307_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"Metabolism"},{"issue":"3","key":"1307_CR4","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-23.","journal-title":"Am J Physiol"},{"key":"1307_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Mancillas-Adame L, Gonz\u00e1lez-Nava V, D\u00edaz Gonz\u00e1lez-Colmenero A, Solis RC, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"1307_CR6","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/brv.12866","volume":"97","author":"Q Xiang","year":"2022","unstructured":"Xiang Q, Tian F, Xu J, Du X, Zhang S, Liu L. New insight into dyslipidemia-induced cellular senescence in atherosclerosis. Biol Rev Camb Philos Soc. 2022;97(5):1844\u201367.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"1","key":"1307_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03536-3","volume":"22","author":"B Yu","year":"2024","unstructured":"Yu B, Li M, Yu Z, Zheng T, Feng X, Gao A, et al. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999\u20132018. BMC Med. 2024;22(1):317.","journal-title":"BMC Med"},{"issue":"1","key":"1307_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02536-3","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Li L, Tang Y, Lin T, Wu J, Wang G, et al. Changes in non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) and cardiovascular disease: insights from CHARLS. Lipids Health Dis. 2025;24(1):112.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1307_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1307_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"7640","key":"1307_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385.","journal-title":"Nature"},{"issue":"1","key":"1307_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12\u201322.","journal-title":"J Clin Invest"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-026-01307-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-026-01307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:15:45Z","timestamp":1778217345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-026-01307-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1186\/s41043-026-01307-9","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All two constituent studies (ELSA and CHARLS) received ethical approval from their respective institutional review boards, and all participants provided written informed consent. This secondary analysis utilized de-identified, publicly available datasets and was conducted in accordance with the Declaration of Helsinki and STROBE guidelines, therefore no additional ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}